Capricor Therapeutics Inc (CAPR) — Cash Flow Reinvestment Rate
Capricor Therapeutics Inc (CAPR) has a Cash Flow Reinvestment Rate of 0.76x as of March 2023, reinvesting $3.21 Million (capex $453.12K plus investments $-2.76 Million) from operating cash flow of $4.21 Million. See Capricor Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Capricor Therapeutics Inc Cash Flow Reinvestment Rate (2014–2022)
Historical reinvestment intensity for Capricor Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see Capricor Therapeutics Inc (CAPR) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Capricor Therapeutics Inc (2014–2022)
Year-by-year capital reinvestment analysis for Capricor Therapeutics Inc. See CAPR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 7.13x | $35.07 Million | $4.92 Million | $3.36 Million | ▲ +1230.6% |
| 2014 | 0.54x | $513.90K | $958.56K | $186.43K | — |